Pro Estro Support II
Natural health product licensed in Canada
- Other names
- Estro Adapt, Estro DTX, Estro Detox, Estro Support, Pro Estro DTX, Pro Estro Support
- Licence holder
- Advanced Orthomolecular Research Inc.
- NPN or DIN-HM
- 80115719
- Status
- Active licence
- Licence date
- 20 January 2022
- Revision date
- 13 February 2026
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Générale (non traditionelle)
If this product were sold in France
- Conditions légales
Brassica oleracea L.: L'étiquetage doit comporter un avertissement recommandant aux personnes ayant une hypothyroïdie ou un traitement de la thyroïde de consulter leur médecin.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Humulus lupulus Extract : Matériel brut sec Extraction ratio : 22.5:1 Dry plant equivalent : 1,350 mg | 60 mg | Not calculated |
| 3,3'-diindolylméthane Source : Brassica oleracea var. italica - plante entière | 54 mg | Not calculated |
| Brassica oleracea var. italica Source : Graine | 150 mg | Not calculated |
Non-medicinal ingredients
Dioxyde de silicium, Stéaryl fumarate de sodium, Poudre de racine de carotte, Cellulose microcristalline, Xylitol, Hypromellose, Acide stéarique
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 2 Capsule | 1 par jour |
Uses authorised in Canada
Text supplied in English because no French text is available.
Helps reduce the severity and duration of symptoms associated with recurrent breast pain (cyclical mastalgia). Helps to support/promote healthy estrogen metabolism/balance. Source of /Provides antioxidants that help fight/protect (cell) against/reduce (the oxidative effects of/the oxidative damage caused by/cell damage caused by) free radicals. (Traditionally) used in Herbal Medicine to help relieve restlessness and/or nervousness (calmative). A factor in the maintenance of good health. Helps to support liver function.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80115719
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
Has the product changed? Photograph the packaging.